Home
About
Overview
Sharing Data
ORCID
Help
History (1)
A phase II study of bryostatin-1 and paclitaxel in patients with advanced non-small cell lung cancer.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
A phase II study of bryostatin-1 and paclitaxel in patients with advanced non-small cell lung cancer.
A phase II study of bryostatin-1 and paclitaxel in patients with advanced non-small cell lung cancer. Lung Cancer. 2003 Feb; 39(2):191-6.
View in:
PubMed
subject areas
Adenocarcinoma
Aged
Antineoplastic Combined Chemotherapy Protocols
Bryostatins
Carcinoma, Non-Small-Cell Lung
Disease-Free Survival
Drug Administration Schedule
Female
Glucocorticoids
Humans
Interleukin-6
Lactones
Lung Neoplasms
Macrolides
Male
Middle Aged
Paclitaxel
Premedication
Survival Rate
T-Lymphocytes
Tumor Necrosis Factor-alpha
authors with profiles
Philip Hoffman
Ann Marie Mauer
Thomas Gajewski
Everett Vokes